Integra Lifesciences Holdings (IART) Retained Earnings (2016 - 2025)
Historic Retained Earnings for Integra Lifesciences Holdings (IART) over the last 17 years, with Q3 2025 value amounting to $425.1 million.
- Integra Lifesciences Holdings' Retained Earnings fell 5381.27% to $425.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $425.1 million, marking a year-over-year decrease of 5381.27%. This contributed to the annual value of $939.9 million for FY2024, which is 73.34% down from last year.
- According to the latest figures from Q3 2025, Integra Lifesciences Holdings' Retained Earnings is $425.1 million, which was down 5381.27% from $430.5 million recorded in Q2 2025.
- Integra Lifesciences Holdings' Retained Earnings' 5-year high stood at $946.9 million during Q4 2023, with a 5-year trough of $425.1 million in Q3 2025.
- Over the past 5 years, Integra Lifesciences Holdings' median Retained Earnings value was $879.1 million (recorded in 2022), while the average stood at $786.3 million.
- As far as peak fluctuations go, Integra Lifesciences Holdings' Retained Earnings skyrocketed by 2504885.71% in 2021, and later tumbled by 5381.27% in 2025.
- Integra Lifesciences Holdings' Retained Earnings (Quarter) stood at $698.6 million in 2021, then rose by 25.85% to $879.1 million in 2022, then increased by 7.71% to $946.9 million in 2023, then dropped by 0.73% to $939.9 million in 2024, then crashed by 54.77% to $425.1 million in 2025.
- Its Retained Earnings was $425.1 million in Q3 2025, compared to $430.5 million in Q2 2025 and $914.6 million in Q1 2025.